 |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cytotoxins and Immunotoxins for Cancer Therapy: Clinical Applications
ISBN: 0415263654, Preisentwicklung...
Gebundene Ausgabe
[EAN: 9780415263658], Neubuch, [PU: Taylor and Francis], Recent advances in cytotoxins and immunotoxins are accelerating our understanding of cancer and leading to more effective therapeutic treatments. Although a large number of articles have been published on these cytotoxins and immunotoxins, this important information has yet to be compiled into one comprehensive resource.For the first time, Cytotoxins and Immunotoxins for Cancer Therapy: Clinical Applications presents state-of-the-art information on various cytotoxins and immunotoxins in a single, highly anticipated publication. The editors bring together leading researchers to summarize their work and discuss clinical trial data concerning some of the most widely studied tumors. The book describes Pseudomonas exotoxin (PE)-based immunotoxins and presents the latest results from clinical trials for the treatment of recurrent glioblastoma and other human cancers. It reviews the role of ricin-based immunotoxins for the treatment of lymphoma, explores several DT-based immunotoxins, and details the preclinical and clinical development of the first FDA-approved cytotoxin. With a focus on clinical developmental approaches to the use of cytotoxins and immunotoxins, this book discusses exciting possibilities for cancer therapy. It is a valuable resource for scientists, researchers, and clinicians involved in the development of new treatments that can help keep cancer under control, and may ultimately lead to a cure.Preface: An Overview of Immunotoxins and Cytotoxins in Clinical TrialsPART 1. PSEUDOMONAS EXOTOXIN (PE)-BASED IMMUNOTOXINS/CYTOTOXINSTargeting of Pseudomonas Exotoxin-based Immunotoxins to Hematologic Malignancies, Robert J. KreitmanInterleukin-4-targeted Cytotoxin for Recurrent Glioblastoma Therapy, Koji Kawakami, Mariko Kawakami, Robert J. Kreitman, and Raj K. PuriInterleukin-13 Receptors and Development of IL-13-Pseudomonas Exotoxin for Human Cancer Therapy, Bharat H. Joshi, Syed R. Husain, Pamela Leland, and Raj K. PuriPART 2. RICIN-BASED IMMUNOTOXINS/CYTOTOXINSRicin Immunotoxins in Lymphomas, Ronald Schnell and Andreas EngertPART 3. DIPHTHERIA TOXIN (DT)-BASED IMMUNOTOXINS/CYTOTOXINS Diphtheria-based Immunotoxins: Targeting Overexpressed Interleukin-13 Receptor and Urokinase-type Plasminogen Activator Receptor on Glioblastoma Multiforme, Edward Rustamzadeh, Walter A. Hall, Deborah Todhunter, and Daniel ValleraDAB389IL-2 (Ontak): Development and Therapeutic Applications, Paul J. Shaughnessy, and Charles F. LeMaistreTransferrin Diphtheria Toxin for Brain Tumor Therapy, Simon Long and Patrick RossiGM-CSF Receptor Targeted Therapy of Human Leukemia, Arthur E. Frankel, Philip D. Hall, Dongsun Cao, Tie Fu Liu, Marlena Moors, Kimberley A. Cohen, Andrew M. Thorburn, and Robert J. KreitmanVEGF-diphtheria toxin for Targeting of Tumor Blood Vessels, Indira V. Subramanian, and Sundaram RamakrishnanPART 4. MISCELLANEOUScBR-96-doxorubicin (SGN-15) for Metastatic Breast Cancer Therapy, Lisle Nabell, Clay B. Siegall, and Mansoor N. SalehAnti-CD33 Calicheamicin Immunoconjugate Therapy of Acute Myeloid Leukemia, Charalambos Andreadis, Selina M. Luger Selina, and Edward A. Stadtmauer Brand NEW unread book. Hard cover bound book.
 |
Books Express (Academic & Professional), Saffron Walden, ESS, United Kingdom [53379852] [Rating: 5 (von 5)] NEW BOOK Versandkosten: EUR 5.77 |
116.26 EUR
Versand: 5.77 EUR
|
Cytotoxins and Immunotoxins for Cancer Therapy, Clinical Applications
2004, ISBN: 0415263654, Preisentwicklung...
Gebundene Ausgabe
[EAN: 9780415263658], Neubuch, [PU: Taylor and Francis(CRC Press)], Medical|Clinical Medicine , (240 pages) Recent advances in cytotoxins and immunotoxins are accelerating our understanding of cancer and leading to more effective therapeutic treatments. Although a large number of articles have been published on these cytotoxins and immunotoxins, this important information has yet to be compiled into one comprehensive resource. For the first time, Cytotoxins and Immunotoxins for Cancer Therapy: Clinical Applications presents state-of-the-art information on various cytotoxins and immunotoxins in a single, highly anticipated publication. The editors bring together leading researchers to summarize their work and discuss clinical trial data concerning some of the most widely studied tumors. The book describes Pseudomonas exotoxin (PE)-based immunotoxins and presents the latest results from clinical trials for the treatment of recurrent glioblastoma and other human cancers. It reviews the role of ricin-based immunotoxins for the treatment of lymphoma, explores several DT-based immunotoxins, and details the preclinical and clinical development of the first FDA-approved cytotoxin. With a focus on clinical developmental approaches to the use of cytotoxins and immunotoxins, this book discusses exciting possibilities for cancer therapy. It is a valuable resource for scientists, researchers, and clinicians involved in the development of new treatments that can help keep cancer under control, and may ultimately lead to a cure.Preface: An Overview of Immunotoxins and Cytotoxins in Clinical Trials PART 1. PSEUDOMONAS EXOTOXIN (PE)-BASED IMMUNOTOXINS/CYTOTOXINS Targeting of Pseudomonas Exotoxin-based Immunotoxins to Hematologic Malignancies, Robert J. Kreitman Interleukin-4-targeted Cytotoxin for Recurrent Glioblastoma Therapy, Koji Kawakami, Mariko Kawakami, Robert J. Kreitman, and Raj K. Puri Interleukin-13 Receptors and Development of IL-13-Pseudomonas Exotoxin for Human Cancer Therapy, Bharat H. Joshi, Syed R. Husain, Pamela Leland, and Raj K. Puri PART 2. RICIN-BASED IMMUNOTOXINS/CYTOTOXINS Ricin Immunotoxins in Lymphomas, Ronald Schnell and Andreas Engert PART 3. DIPHTHERIA TOXIN (DT)-BASED IMMUNOTOXINS/CYTOTOXINS Diphtheria-based Immunotoxins: Targeting Overexpressed Interleukin-13 Receptor and Urokinase-type Plasminogen Activator Receptor on Glioblastoma Multiforme, Edward Rustamzadeh, Walter A. Hall, Deborah Todhunter, and Daniel Vallera DAB389IL-2 (Ontak): Development and Therapeutic Applications, Paul J. Shaughnessy, and Charles F. LeMaistre Transferrin Diphtheria Toxin for Brain Tumor Therapy, Simon Long and Patrick Rossi GM-CSF Receptor Targeted Therapy of Human Leukemia, Arthur E. Frankel, Philip D. Hall, Dongsun Cao, Tie Fu Liu, Marlena Moors, Kimberley A. Cohen, Andrew M. Thorburn, and Robert J. Kreitman VEGF-diphtheria toxin for Targeting of Tumor Blood Vessels, Indira V. Subramanian, and Sundaram Ramakrishnan PART 4. MISCELLANEOUS cBR-96-doxorubicin (SGN-15) for Metastatic Breast Cancer Therapy, Lisle Nabell, Clay B. Siegall, and Mansoor N. Saleh Anti-CD33 Calicheamicin Immunoconjugate Therapy of Acute Myeloid Leukemia, Charalambos Andreadis, Selina M. Luger Selina, and Edward A. Stadtmauer (Hardback)
|
Stratford Books, United Kingdom, ., United Kingdom [7096470] [Rating: 5 (von 5)] NEW BOOK Versandkosten: EUR 9.77 |
112.83 EUR
Versand: 9.77 EUR
|
